|
1
|
Cooper CL and Marshall J: Occupational
sources of stress: A review of the literature relating to coronary
heart disease and mental ill healthFrom Stress to Wellbeing. Cooper
CL: I. Palgrave Macmillan; UK: pp. 3–23. 2013, View Article : Google Scholar
|
|
2
|
Dawber TR, Moore FE and Mann GV: Coronary
heart disease in the Framingham study. Am J Public Health Nations
Health. 47:4–24. 1957. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Canoy D, Cairns BJ, Balkwill A, Wright FL,
Khalil A, Beral V, Green J and Reeves G: Million Women Study
Collaborators: Hypertension in pregnancy and risk of coronary heart
disease and stroke: A prospective study in a large UK cohort. Int J
Cardiol. 222:1012–1018. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nordestgaard BG, Chapman MJ, Humphries SE,
Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ,
Defesche JC, et al: European Atherosclerosis Society Consensus
Panel: Familial hypercholesterolaemia is underdiagnosed and
undertreated in the general population: guidance for clinicians to
prevent coronary heart disease: consensus statement of the European
Atherosclerosis Society. Eur Heart J. 34:3478–3490. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Santulli G: Epidemiology of cardiovascular
disease in the 21st century: Updated numbers and updated facts. J
Cardiovasc Dis. 1:1–2. 2013.
|
|
6
|
Richard E, von Muhlen D, Barrett-Connor E,
Alcaraz J, Davis R and McCarthy JJ: Modification of the effects of
estrogen therapy on HDL cholesterol levels by polymorphisms of the
HDL-C receptor, SR-BI: The Rancho Bernardo Study. Atherosclerosis.
180:255–262. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yakushiji E, Ayaori M, Nishida T, Shiotani
K, Takiguchi S, Nakaya K, Uto-Kondo H, Ogura M, Sasaki M, Yogo M,
et al: Probucol-oxidized products, spiroquinone and diphenoquinone,
promote reverse cholesterol transport in mice. Arterioscler Thromb
Vasc Biol. 36:591–597. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Artom N, Montecucco F, Dallegri F and
Pende A: Carotid atherosclerotic plaque stenosis: The stabilizing
role of statins. Eur J Clin Invest. 44:1122–1134. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yamashita S, Masuda D and Matsuzawa Y: Did
we abandon probucol too soon? Curr Opin Lipidol. 26:304–316. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fu CG, Gao ZY and Wang PL: Study on the
diagnostic criteria for coronary heart disease patients of blood
stasis syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi. 32:1285–1286.
2012.(In Chinese). PubMed/NCBI
|
|
11
|
Taylor RS, Brown A, Ebrahim S, Jolliffe J,
Noorani H, Rees K, Skidmore B, Stone JA, Thompson DR and Oldridge
N: Exercise-based rehabilitation for patients with coronary heart
disease: Systematic review and meta-analysis of randomized
controlled trials. Am J Med. 116:682–692. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu Y, Hajifathalian K, Ezzati M, Woodward
M, Rimm EB and Danaei G: Global Burden of Metabolic Risk Factors
for Chronic Diseases Collaboration (BMI Mediated Effects):
Metabolic mediators of the effects of body-mass index, overweight,
and obesity on coronary heart disease and stroke: A pooled analysis
of 97 prospective cohorts with 1•8 million participants. Lancet.
383:970–983. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ito T, Kakihana Y and Maruyama I:
Thrombomodulin as an intravascular safeguard against inflammatory
and thrombotic diseases. Expert Opin Ther Targets. 20:151–158.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li JF, Chen S, Feng JD, Zhang MY and Liu
XX: Probucol via inhibition of NHE1 attenuates LPS-accelerated
atherosclerosis and promotes plaque stability in vivo. Exp Mol
Pathol. 96:250–256. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Janoudi A, Shamoun FE, Kalavakunta JK and
Abela GS: Cholesterol crystal induced arterial inflammation and
destabilization of atherosclerotic plaque. Eur Heart J.
37:1959–1967. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu H, Jin X, Zhao J, Dong Z, Ma X, Xu F,
Huang W, Liu G, Zou Y, Wang K, et al: Probucol protects against
atherosclerosis through lipid-lowering and suppressing immune
maturation of CD11c+ dendritic cells in STZ-induced
diabetic LDLR−/− mice. J Cardiovasc Pharmacol.
65:620–627. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li S, Liang J, Niimi M, Waqar Bilal A,
Kang D, Koike T, Wang Y, Shiomi M and Fan J: Probucol suppresses
macrophage infiltration and MMP expression in atherosclerotic
plaques of WHHL rabbits. J Atheroscler Thromb. 21:648–658. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Martin FA, McLoughlin A, Rochfort KD,
Davenport C, Murphy RP and Cummins PM: Regulation of thrombomodulin
expression and release in human aortic endothelial cells by cyclic
strain. PLoS One. 9:e1082542014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen PS, Wang KC, Chao TH, Chung HC, Tseng
SY, Luo CY, Shi GY, Wu HL and Li YH: Recombinant thrombomodulin
exerts anti-autophagic action in endothelial cells and provides
anti-atherosclerosis effect in apolipoprotein E deficient mice. Sci
Rep. 7:32842017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hong SC, Zhao SP, Liu Q and Wu ZH: Effect
of the anti-oxidant probucol on soluble thrombomodulin (sTM) in
hypercholesterolemic rabbits. Int J Cardiol. 123:180–182. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamashita S, Masuda D, Ohama T, Arai H,
Bujo H, Kagimura T, Kita T, Matsuzaki M, Saito Y, Fukushima M, et
al: PROSPECTIVE Study Group: Rationale and design of the
PROSPECTIVE trial: Probucol trial for secondary prevention of
atherosclerotic events in patients with prior coronary heart
disease. J Atheroscler Thromb. 23:746–756. 2016. View Article : Google Scholar : PubMed/NCBI
|
